Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 217

1.

Butyricimonas faecalis sp. nov., isolated from human faeces and emended description of the genus Butyricimonas.

Le Roy T, Van der Smissen P, Paquot A, Delzenne N, Muccioli GG, Collet JF, Cani PD.

Int J Syst Evol Microbiol. 2019 Jan 30. doi: 10.1099/ijsem.0.003249. [Epub ahead of print]

PMID:
30698516
2.

Intestinal epithelial N-acylphosphatidylethanolamine phospholipase D links dietary fat to metabolic adaptations in obesity and steatosis.

Everard A, Plovier H, Rastelli M, Van Hul M, de Wouters d'Oplinter A, Geurts L, Druart C, Robine S, Delzenne NM, Muccioli GG, de Vos WM, Luquet S, Flamand N, Di Marzo V, Cani PD.

Nat Commun. 2019 Jan 28;10(1):457. doi: 10.1038/s41467-018-08051-7.

3.

Targeting gut microbiota with a complex mix of dietary fibers improves metabolic diseases.

Cani PD.

Kidney Int. 2019 Jan;95(1):14-16. doi: 10.1016/j.kint.2018.11.012. No abstract available.

PMID:
30606413
4.

Microbiota and metabolites in metabolic diseases.

Cani PD.

Nat Rev Endocrinol. 2019 Feb;15(2):69-70. doi: 10.1038/s41574-018-0143-9. No abstract available.

PMID:
30602737
5.

Elevated high density lipoprotein cholesterol and low grade systemic inflammation is associated with increased gut permeability in normoglycemic men.

Robertson MD, Pedersen C, Hinton PJ, Mendis ASJR, Cani PD, Griffin BA.

Nutr Metab Cardiovasc Dis. 2018 Dec;28(12):1296-1303. doi: 10.1016/j.numecd.2018.07.006. Epub 2018 Aug 1.

PMID:
30459055
6.

Erratum. The Transplantation of ω3 PUFA-Altered Gut Microbiota of fat-1 Mice to Wild-Type Littermates Prevents Obesity and Associated Metabolic Disorders. Diabetes 2018;67:1512-1523.

Bidu C, Escoula Q, Bellenger S, Spor A, Galan M, Geissler A, Bouchot A, Dardevet D, Morio-Liondor B, Cani PD, Lagrost L, Narce M, Bellenger J.

Diabetes. 2019 Jan;68(1):235. doi: 10.2337/db19-er01a. Epub 2018 Nov 19. No abstract available.

7.

Inflammation and Gut-Brain Axis During Type 2 Diabetes: Focus on the Crosstalk Between Intestinal Immune Cells and Enteric Nervous System.

Bessac A, Cani PD, Meunier E, Dietrich G, Knauf C.

Front Neurosci. 2018 Oct 10;12:725. doi: 10.3389/fnins.2018.00725. eCollection 2018. Review.

8.

Dysregulated Microbial Fermentation of Soluble Fiber Induces Cholestatic Liver Cancer.

Singh V, Yeoh BS, Chassaing B, Xiao X, Saha P, Aguilera Olvera R, Lapek JD Jr, Zhang L, Wang WB, Hao S, Flythe MD, Gonzalez DJ, Cani PD, Conejo-Garcia JR, Xiong N, Kennett MJ, Joe B, Patterson AD, Gewirtz AT, Vijay-Kumar M.

Cell. 2018 Oct 18;175(3):679-694.e22. doi: 10.1016/j.cell.2018.09.004.

PMID:
30340040
9.

Klebsiella oxytoca expands in cancer cachexia and acts as a gut pathobiont contributing to intestinal dysfunction.

Pötgens SA, Brossel H, Sboarina M, Catry E, Cani PD, Neyrinck AM, Delzenne NM, Bindels LB.

Sci Rep. 2018 Aug 17;8(1):12321. doi: 10.1038/s41598-018-30569-5.

10.

Severe obesity and gut microbiota: does bariatric surgery really reset the system?

Cani PD.

Gut. 2019 Jan;68(1):5-6. doi: 10.1136/gutjnl-2018-316815. Epub 2018 Jul 10. No abstract available.

11.

Impact of Intestinal Peptides on the Enteric Nervous System: Novel Approaches to Control Glucose Metabolism and Food Intake.

Abot A, Cani PD, Knauf C.

Front Endocrinol (Lausanne). 2018 Jun 22;9:328. doi: 10.3389/fendo.2018.00328. eCollection 2018. Review.

12.

Human gut microbiome: hopes, threats and promises.

Cani PD.

Gut. 2018 Sep;67(9):1716-1725. doi: 10.1136/gutjnl-2018-316723. Epub 2018 Jun 22. Review.

13.

The gut microbiota metabolite indole alleviates liver inflammation in mice.

Beaumont M, Neyrinck AM, Olivares M, Rodriguez J, de Rocca Serra A, Roumain M, Bindels LB, Cani PD, Evenepoel P, Muccioli GG, Demoulin JB, Delzenne NM.

FASEB J. 2018 Jun 15:fj201800544. doi: 10.1096/fj.201800544. [Epub ahead of print]

14.

Prebiotics Supplementation Impact on the Reinforcing and Motivational Aspect of Feeding.

Delbès AS, Castel J, Denis RGP, Morel C, Quiñones M, Everard A, Cani PD, Massiera F, Luquet SH.

Front Endocrinol (Lausanne). 2018 May 29;9:273. doi: 10.3389/fendo.2018.00273. eCollection 2018.

15.

Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer.

Cani PD, Jordan BF.

Nat Rev Gastroenterol Hepatol. 2018 Nov;15(11):671-682. doi: 10.1038/s41575-018-0025-6. Review.

PMID:
29844585
16.

The DPP-4 inhibitor vildagliptin impacts the gut microbiota and prevents disruption of intestinal homeostasis induced by a Western diet in mice.

Olivares M, Neyrinck AM, Pötgens SA, Beaumont M, Salazar N, Cani PD, Bindels LB, Delzenne NM.

Diabetologia. 2018 Aug;61(8):1838-1848. doi: 10.1007/s00125-018-4647-6. Epub 2018 May 25.

17.

American Gut: an Open Platform for Citizen Science Microbiome Research.

McDonald D, Hyde E, Debelius JW, Morton JT, Gonzalez A, Ackermann G, Aksenov AA, Behsaz B, Brennan C, Chen Y, DeRight Goldasich L, Dorrestein PC, Dunn RR, Fahimipour AK, Gaffney J, Gilbert JA, Gogul G, Green JL, Hugenholtz P, Humphrey G, Huttenhower C, Jackson MA, Janssen S, Jeste DV, Jiang L, Kelley ST, Knights D, Kosciolek T, Ladau J, Leach J, Marotz C, Meleshko D, Melnik AV, Metcalf JL, Mohimani H, Montassier E, Navas-Molina J, Nguyen TT, Peddada S, Pevzner P, Pollard KS, Rahnavard G, Robbins-Pianka A, Sangwan N, Shorenstein J, Smarr L, Song SJ, Spector T, Swafford AD, Thackray VG, Thompson LR, Tripathi A, Vázquez-Baeza Y, Vrbanac A, Wischmeyer P, Wolfe E, Zhu Q; American Gut Consortium , Knight R.

mSystems. 2018 May 15;3(3). pii: e00031-18. doi: 10.1128/mSystems.00031-18. eCollection 2018 May-Jun.

18.

The Transplantation of ω3 PUFA-Altered Gut Microbiota of fat-1 Mice to Wild-Type Littermates Prevents Obesity and Associated Metabolic Disorders.

Bidu C, Escoula Q, Bellenger S, Spor A, Galan M, Geissler A, Bouchot A, Dardevet D, Morio-Liondor B, Cani PD, Lagrost L, Narce M, Bellenger J.

Diabetes. 2018 Aug;67(8):1512-1523. doi: 10.2337/db17-1488. Epub 2018 May 23. Erratum in: Diabetes. 2019 Jan;68(1):235.

19.

Increased gut permeability in cancer cachexia: mechanisms and clinical relevance.

Bindels LB, Neyrinck AM, Loumaye A, Catry E, Walgrave H, Cherbuy C, Leclercq S, Van Hul M, Plovier H, Pachikian B, Bermúdez-Humarán LG, Langella P, Cani PD, Thissen JP, Delzenne NM.

Oncotarget. 2018 Apr 6;9(26):18224-18238. doi: 10.18632/oncotarget.24804. eCollection 2018 Apr 6.

20.

Inulin Improves Postprandial Hypertriglyceridemia by Modulating Gene Expression in the Small Intestine.

Hiel S, Neyrinck AM, Rodriguez J, Pachikian BD, Bouzin C, Thissen JP, Cani PD, Bindels LB, Delzenne NM.

Nutrients. 2018 Apr 25;10(5). pii: E532. doi: 10.3390/nu10050532.

Supplemental Content

Loading ...
Support Center